HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abnormal expression of CD antigens in mastocytosis.

Abstract
Human mast cells are myeloid cells derived from human pluripotential CD34+ stem cells. Normal mast cells exhibit a myeloid immunophenotype characterized by the expression of CD117, CD33 and Fc epsilon RI in the absence of reactivity for CD14, CD15 and lymphoid-lineage-associated antigens. Multiparametric flow-cytometric studies have shown that mast cells from mastocytosis display unique immunophenotypic characteristics, including coexpression of CD2 and CD25 antigens together with abnormally high levels of the activation-related antigens CD35, CD63 and CD69 among others. Such aberrant immunophenotypic features are of great relevance in the diagnosis and differential diagnosis of the disease, flow-cytometric immunophenotyping of mast cells representing the most sensitive method for the diagnosis of tissue involvement in mastocytosis. From the pathogenetic point of view, the immunophenotypical patterns described suggest the existence of profound changes regarding the adhesion and activation status of mast cells in mastocytosis and may represent a useful tool for a better understanding of some pathophysiological aspects of the disease.
AuthorsLuis Escribano, Beatriz Díaz-Agustín, Rosa Núñez, Aranzazu Prados, Ramón Rodríguez, Alberto Orfao
JournalInternational archives of allergy and immunology (Int Arch Allergy Immunol) Vol. 127 Issue 2 Pg. 127-32 (Feb 2002) ISSN: 1018-2438 [Print] Switzerland
PMID11919422 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright 2002 S. Karger AG, Basel
Chemical References
  • Antigens, CD
Topics
  • Antigens, CD (analysis)
  • Bone Marrow Cells (chemistry)
  • Humans
  • Mast Cells (chemistry)
  • Mastocytosis (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: